» Authors » Tian-Tian Zou

Tian-Tian Zou

Explore the profile of Tian-Tian Zou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 351
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu K, Xia L, Chen H, Zou T, Zhang Y, Zhang P, et al.
Nat Sci Sleep . 2024 Dec; 16:1907-1919. PMID: 39655316
Purpose: The purpose of this study was to look into the relationship between pre-sleep arousal state, sleep reactivity, and serum levels of neuroendocrine hormones (cortisol, copeptin, and corticotropin-releasing hormone) in...
2.
Shen X, Xie S, Zheng X, Zou T, Hu B, Xu J, et al.
Exp Hematol Oncol . 2024 Feb; 13(1):20. PMID: 38388466
Background: Hepatocellular carcinoma (HCC) is closely associatedwith chronic liver diseases, particularly liver cirrhosis, which has an altered extracellular matrix (ECM) composition. The influence and its mechanism of the cirrhotic-ECM on...
3.
Zhu L, Sun H, Wang S, Huang S, Zheng Y, Wang C, et al.
J Hematol Oncol . 2020 Nov; 13(1):152. PMID: 33168028
Exosomes are a subset of extracellular vesicles that carry specific combinations of proteins, nucleic acids, metabolites, and lipids. Mounting evidence suggests that exosomes participate in intercellular communication and act as...
4.
Zheng J, Li Y, Yan Y, Shi H, Zou T, Shao W, et al.
Front Genet . 2020 Aug; 11:816. PMID: 32793290
Systemic sclerosis-associated with pulmonary arterial hypertension (SSc-PAH) is still a major cause of SSc related deaths. Early diagnosis and prompt treatment are crucial to reduce the mortality of patients with...
5.
Zou T, Zhou Y, Zhou X, Liu W, Van Poucke S, Wu W, et al.
Horm Metab Res . 2018 Sep; 50(9):683-689. PMID: 30184562
Although several risk factors for metabolic syndrome (MetS) have been reported, there are few clinical scores that predict its incidence. Therefore, we created and validated a risk score for prediction...
6.
Zou T, Zhang C, Zhou Y, Han Y, Xiong J, Wu X, et al.
Eur J Gastroenterol Hepatol . 2018 Apr; 30(7):747-755. PMID: 29683979
Lifestyle interventions remain the first-line therapy for nonalcoholic fatty liver disease (NAFLD). This study aims to evaluate the individual impact of exercise and/or dietary interventions on the level of alanine...
7.
Zhou Y, Zhou Y, Zheng J, Liu W, Van Poucke S, Zou T, et al.
Clin Chim Acta . 2017 Oct; 475:44-50. PMID: 28964832
Background: Several non-invasive diagnostic scores for non-alcoholic fatty liver (NAFL) have been developed, but the clinical application is limited because of their complexity. Aim: To develop and validate an easy-to-calculate...
8.
Zhou Y, Zheng J, Zhou Y, Han Y, Zou T, Liu W, et al.
Eur J Gastroenterol Hepatol . 2017 Jul; 29(10):1166-1173. PMID: 28746121
Background And Aim: Upper gastrointestinal bleeding (UGIB) is a complication with a high mortality rate in critically ill patients presenting with cirrhosis. Today, there exist few accurate scoring models specifically...
9.
Zheng J, Han Y, Zou T, Zhou Y, Sun D, Zhong J, et al.
Expert Rev Gastroenterol Hepatol . 2017 Jul; 11(11):1009-1018. PMID: 28708431
The outcome of a comparative efficacy and safety of vasoconstrictor therapies for treatment of patients with type 1 hepatorenal syndrome (HRS-1) remain inconclusive. Areas covered: We searched literature databases for...
10.
Huang G, Zheng J, Zou T, Chen Y, Shi K, Van Poucke S, et al.
J Clin Transl Hepatol . 2017 May; 5(1):35-42. PMID: 28507925
Platelet-to-lymphocyte ratio (PLR) has been shown to predict prognosis of cancers. We aimed to evaluate the prognostic value of stratification of PLR in patients after curative liver resection (CLR) for...